References
- Centers for Disease Control and Prevention. Outbreaks Ebola (Ebola Virus Disease). 2023 https://www.cdc.gov/vhf/ebola/outbreaks/index-2018.html
- World Health Organization. Ebola haemorrhagic fever in Zaire, 1976. Bulletin of the World Health Organization. 1978;56:271–293.
- Centers for Disease Control and Prevention. Ebola (Ebola Virus Disease) | CDC. Ebola (Ebola Virus Disease). 2018. p. 1. https://www.cdc.gov/vhf/ebola/index.html.
- Weyer J, Grobbelaar A, Blumberg L. Ebola virus disease: history, epidemiology and outbreaks. Curr Infect Dis Rep. 2015;17(5)Current Medicine Group LLC:480. doi:10.1007/s11908-015-0480-y.
- Wiwanitkit V. Ebola virus disease. J Chin Med Assoc. 2015;78(4):264. https://www.sciencedirect.com/science/article/pii/S1726490115000593.
- Maxmen A. World’s second-deadliest ebola outbreak ends in democratic republic of the Congo. Nature. 2020; doi:10.1038/d41586-020-01950-0.
- Harris M, Boakye-Agyemang C. New Ebola outbreak detected in northwest Democratic Republic of the Congo; WHO surge team supporting the response. World Health Organization. 2020. https://www.who.int/news-room/detail/01-06-2020-new-ebola-outbreak-detected-in-northwest-democratic-republic-of-the-congo-who-surge-team-supporting-the-response
- Centers for Disease Control and Prevention. 2020 Democratic Republic of the Congo, Equateur Province (ongoing) | Democratic Republic of Congo | Outbreaks | Ebola (Ebola Virus Disease) | CDC. 2020. https://www.cdc.gov/vhf/ebola/outbreaks/drc/2020-june.html
- Measles: the never-ending fight against one of the world’s most contagious diseases - Democratic Republic of the Congo | ReliefWeb. 2023. https://reliefweb.int/report/democratic-republic-congo/measles-never-ending-fight-against-one-worlds-most-contagious-diseases
- Nachega JB, Mbala-Kingebeni P, Otshudiema J, et al. The colliding epidemics of COVID-19, ebola, and measles in the democratic republic of the Congo. Lancet Glob Health. 2020;8(8):e991–e992. doi:10.1016/S2214-109X(20)30281-3.
- Judson S, Prescott J, Munster V. Understanding ebola virus transmission. Viruses. MDPI AG. 2015;7(2):511–521. doi:10.3390/v7020511.
- World Health Organization. What we know about transmission of the ebola virus among humans. Media centre; news releases. 2014. p. 2014–2016. https://www.who.int/mediacentre/news/ebola/06-october-2014/en/
- Rewar S, Mirdha D. Transmission of ebola virus disease: an overview. Ann Glob Health. 2014;80(6):444–451. Elsevier USA doi:10.1016/j.aogh.2015.02.005.
- Wilder-Smith A. COVID-19 in comparison with other emerging viral diseases: risk of geographic spread via travel. Trop Dis Travel Med Vaccines. 2021;7(1):3. doi:10.1186/s40794-020-00129-9.
- Tomori O, Kolawole MO. Ebola virus disease: current vaccine solutions. Curr Opin Immunol. 2021; 71:27–33. https://www.sciencedirect.com/science/article/pii/S0952791521000285.
- Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345(6202):1369–1372. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431643/.
- Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire ebola virus disease in Guinea. N Engl J Med. 2014;371(15):1418–1425. doi:10.1056/NEJMoa1404505.
- Haque A, Hober D, Blondiaux J. Addressing therapeutic options for ebola virus infection in current and future outbreaks. Antimicrob Agents Chemother. 2015;59(10):5892–5902. doi:10.1128/AAC.01105-15.
- Bartsch SM, Gorham K, Lee BY. The cost of an ebola case. Pathog Glob Health. 2015;109(1):4–9. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L603981462.
- Bowles J, Hjort J, Melvin T, et al. Ebola, jobs and economic activity in Liberia. J Epidemiol Community Health. 2016;70(3):271–277. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L614446481. doi:10.1136/jech-2015-205959.
- Da Costa S. The impact of the ebola crisis on mortality and welfare in Liberia. Health Econ. 2020;29(12):1517–1532. doi:10.1002/hec.4150.
- Elmahdawy M, Elsisi GH, Carapinha J, et al. Ebola virus epidemic in west africa: global health economic challenges, lessons learned, and policy recommendations. Value Health Reg Issues. 2017;13:67–70. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L618232240. doi:10.1016/j.vhri.2017.08.003.
- Huber C, Finelli L, Stevens W. The economic and social burden of the 2014 ebola outbreak in west africa. J Infect Dis. 2018;218(suppl_5):S698–S704. https://academic.oup.com/jid/article-abstract/218/suppl_5/S698/5129071. doi:10.1093/infdis/jiy213.
- Kirigia JM, P A, Masiye F, et al. Indirect costs associated with deaths from the ebola virus disease in west africa. Infect Dis Poverty. 2015;4(1):45. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L606662254. doi:10.1186/s40249-015-0079-4.
- Kirigia JM, Muthuri RNDK, Muthuri NG. The monetary value of human lives lost through ebola virus disease in the democratic republic of Congo in 2019. BMC Public Health. 2019;19(1):1218. doi:10.1186/s12889-019-7542-2.
- Kum FV, Olayiwola S, Aloysius NM. The impact of ebola virus disease on government expenditure in Sierra Leone. In: Socio-cultural dimensions of emerging infectious diseases in Africa. Springer Nature Switzerland AG; 2019. p. 75–90. https://www.worldbank.org/en/topic/macroeconomics/publication/2014-2015-west-africa-ebola-crisis-impact-update
- Morrison IDL, Anderson BI, Brower AI, et al. Macroeconomic impact of ebola outbreaks in Sub-Saharan africa and potential mitigation of GDP loss with prophylactic ebola vaccination programs. PLOS ONE. 2023;18(4):e0283721. doi:10.1371/journal.pone.0283721.t001.
- Olugasa BO, Oshinowo OY, Odigie EA. Preventive and social cost implications of ebola virus disease (EVD) outbreak on selected organizations in Lagos state, Nigeria. Pan Afr Med J. 2015;22(Supp 1):20–20. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L616010262. doi:10.11604/pamj.supp.2015.22.1.6673.
- Onyekuru NA, Ihemezie EJ, Ezea CP, et al. Impacts of ebola disease outbreak in west africa: implications for government and public health preparedness and lessons from COVID-19-NC-ND license. Sci Afr. 2023;19:e01513. (http://creativecommons.org/licenses/by-nc-nd/4.0/). doi:10.1016/j.sciaf.2022.e01513.
- Zacharowski K, Brodt HR, Wolf T. Medical treatment of an ebola-infected doctor - Ethics over costs? Lancet. 2015;385(9969):685–685. doi:10.1016/S0140-6736(15)60279-3.
- Zeng W, Samaha H, Yao M, et al. The cost of public health interventions to respond to the 10th ebola outbreak in the democratic republic of the Congo. BMJ Glob Health. 2023; 8(10):e012660. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583089/. doi:10.1136/bmjgh-2023-012660.
- Huo X, Shi G, Li X, et al. Knowledge and attitudes about ebola vaccine among the general population in Sierra Leone. Vaccine. 2016;34(15):1767–1772. doi:10.1016/j.vaccine.2016.02.046.
- Kpanake L, Sorum PC, Mullet É. Willingness to get vaccinated against ebola: a mapping of guinean people positions. Hum Vaccin Immunother. 2018;14(10):2391–2396. doi:10.1080/21645515.2018.1480236.
- Mudatsir M, Anwar S, Karunia Fajar J, et al. Willingness-to-pay for a hypothetical ebola vaccine in Indonesia: a cross-sectional study in Aceh. F1000Res. 2019;8:1441. doi:10.12688/f1000research.20144.1.
- Painter JE, von Fricken ME, Viana de O, et al. Willingness to pay for an ebola vaccine during the 2014–2016 ebola outbreak in west africa: results from a U.S. National sample. Hum Vaccin Immunother. 2018;14(7):1665–1671. doi:10.1080/21645515.2018.1423928.
- Ughasoro MD, Esangbedo DO, Tagbo BN, et al. Acceptability and willingness-to-pay for a hypothetical ebola virus vaccine in Nigeria. PLoS Negl Trop Dis. 2015;9(6):e0003838. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L605059981. doi:10.1371/journal.pntd.0003838.
- Obeng-Kusi M, Habila MA, Roe DJ, et al. Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-Middle-income countries. J Med Econ. 2021;24(sup1):1–13. doi:10.1080/13696998.2021.2002092.
- Kellerborg K, Brouwer W, Van Baal P. Costs and benefits of early response in the ebola virus disease outbreak in Sierra Leone. Cost Eff Resour Alloc. 18(1):13. doi:10.1186/s12962-020-00207-x.
- Abraham N, Jain A, Harrison D, et al. 70 A cost analysis of a county hospital emergency department’s ebola virus disease preparedness. Ann Emerg Med. 2015;66(4):S25. doi:10.1016/j.annemergmed.2015.07.102.
- Herstein JJ, Biddinger PD, Kraft CS, et al. Initial costs of ebola treatment centers in the United States. Emerg Infect Dis. 2016;22(2):350–352. doi:10.3201/eid2202.151431.
- Herstein JJ, Le AB, McNulty LA, et al. Update on ebola treatment center costs and sustainability, United States, 2019. Emerg Infect Dis. 2020;26(5):1007–1009. doi:10.3201/eid2605.191245.
- Mccullough JM, Fowle N, Sylvester T, et al. Cost analysis of 3 concurrent public health response events: financial impact of measles outbreak, super bowl surveillance, and ebola surveillance in maricopa county. J Public Health Manag Pract. 2019;25(4):357–365. doi:10.1097/PHH.0000000000000818.
- Morgan DJ, Braun B, Milstone AM, et al. Lessons learned from hospital ebola preparation. Infect Control Hosp Epidemiol. 2015;36(6):627–631. doi:10.1017/ice.2015.61.
- Ripper J, Nagurka R, Patel M, et al. 98 The cost of safety: implementation, maintenance, and patient care expenses of an emergency department ebola extended treatment area. Annals of Emergency Medicine. 2015;66(4):S34–S35. doi:10.1016/j.annemergmed.2015.07.130.
- Simonsen KA, Phipps AR, Hall M, et al. Costs associated with ebola preparedness at a freestanding pediatric assessment center. Infect Control Hosp Epidemiol. 2017;38(11):1367–1369. doi:10.1017/ice.2017.193.
- Smit MA, Rasinski KA, Braun BI, et al. Ebola preparedness resources for acute-care hospitals in the United States: a cross-sectional study of costs, benefits, and challenges. Infect Control Hosp Epidemiol. 2017;38(4):405–410. doi:10.1017/ice.2017.6.
- Suijkerbuijk AWM, Swaan CM, Mangen MJJ, et al. Ebola in The Netherlands, 2014–2015: costs of preparedness and response. Eur J Health Econ. 2018;19(7):935–943. doi:10.1007/s10198-017-0940-4.
- Tariq H, Emes DT, Boo YY, et al. Economic impact of ebola virus disease outbreak on an extractive firm: a case study. UCL Open Environ. 2020;2:e007. doi:10.14324/111.444/ucloe.000007.
- Yacisin K, Balter S, Fine A, et al. Ebola virus disease in a humanitarian aid worker—New York city, october 2014. Mortality Weekly Report. 2015;64:321–323.
- Boddie C. Federal funding in support of ebola medical countermeasures R&D. Health Secur. 2015;13(1):3–8. doi:10.1089/hs.2015.0001.
- Fitchett JRA, Lichtman A, Soyode DT, et al. Ebola research funding: a systematic analysis, 1997-2015. J Glob Health. 2016;6(2):020703. doi:10.7189/jogh.06.020703.
- Shimizu K, Checchi F, Warsame A. Disparities in health financing allocation among infectious diseases in ebola virus disease (EVD)-affected countries, 2005–2017. Healthcare (Switzerland). 2022;10(2):179. doi:10.3390/healthcare10020179.
- World Bank Group. World Bank Mobilizes US$300 Million to Finance the Ebola Response in Democratic Republic of Congo. World Bank Fiscal Report. 2019 cited 2020 Jul 6]. https://www.worldbank.org/en/news/press-release/2019/07/24/world-bank-mobilizes-us300-million-to-finance-the-ebola-response-in-democratic-republic-of-congo.
- Gavi. The Vaccine Alliance. Gavi boosts funding for Ebola outbreak response. https://www.gavi.org/news/media-room/gavi-boosts-funding-ebola-outbreakresponse.
- Office of the United Nations Special Envoy on Ebola. Resources for Results V. 2015. https://ebolaresponse.un.org/sites/default/files/resources_for_results_v.pdf.
- World Bank. 2014-2015 West africa ebola crisis: impact update. World Bank Fiscal Report. 2016.
- World Health Organization. Funding. 2020. https://www.who.int/emergencies/diseases/ebola/drc-2019/funding
- Mauskopf J, Standaert B, Connolly MP, et al. Economic analysis of vaccination programs: an ISPOR good practices for outcomes research task force report. Value in Health. 2018;21(10):1133–1149. https://www.valueinhealthjournal.com/article/S1098-3015(18)33267-4/fulltext?_returnURL=https%3A//linkinghub.elsevier.com/retrieve/pii/S1098301518332674%3Fshowall%3Dtrue. doi:10.1016/j.jval.2018.08.005.
- WHO Guide on Standardization of Economic Evaluations of Immunization Programmes. 2023. https://www.who.int/publications-detail-redirect/WHO-IVB-19.10
- Clark DV, Kibuuka H, Millard M, et al. Long-term sequelae after ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis. 2015;15(8):905–912. doi:10.1016/S1473-3099(15)70152-0.
- Mohammed H, Vandy AO, Stretch R, et al. Sequelae and other conditions in ebola virus disease survivors, Sierra Leone, 2015. Emerg Infect Dis. 2017;23(1):66–73. doi:10.3201/eid2301.160631.
- Varkey JB, Shantha JG, Crozier I, et al. Persistence of ebola virus in ocular fluid during convalescence. N Engl J Med. 2015;372(25):2423–2427. doi:10.1056/NEJMoa1500306.
- Smith J, Lipsitch M, Almond JW. Vaccine production, distribution, access, and uptake. Lancet. 2011;378(9789):428–438. doi:10.1016/S0140-6736(11)60478-9.
- Hardt K, Bonanni P, King S, et al. Vaccine strategies: optimising outcomes. Vaccine. 2016;34(52):6691–6699. doi:10.1016/j.vaccine.2016.10.078.
- Jit M, Hutubessy R. Methodological challenges to economic evaluations of vaccines: is a common approach still possible? Appl Health Econ Health Policy. 2016;14(3):245–252. doi:10.1007/s40258-016-0224-7.
- Walker DG, Hutubessy R, Beutels P. WHO guide for standardisation of economic evaluations of immunization programmes. Vaccine. 2010;28(11):2356–2359. https://www.sciencedirect.com/science/article/pii/S0264410X09008986.
- Pitt C, Vassall A, Teerawattananon Y, et al. Foreword: health economic evaluations in low- and Middle-income countries: methodological issues and challenges for priority setting. Health Econ. 2016;25(Suppl 1):1–5. doi:10.1002/hec.3319.
- Griffiths UK, Legood R, Pitt C. Comparison of cconomic evaluation methods across low-income, Middle-income and high-income countries: what are the differences and why? Health Econ. 2016;25 (Suppl 1):29–41. doi:10.1002/hec.3312.